John Athanasopoulos

Statistics

Publications

Citations

303

H-Index

Active since

2004

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Target (United States)

Angiogenesis Foundation

John Athanasopoulos is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

Publications per year

2004–2012

Publications

An affinity selection–mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial libraries

D. Allen Annis, John Athanasopoulos, Patrick J. Curran et al. · International Journal of Mass Spectrometry · 2004 · 99 citations

Pharmacy, Chemistry, Medicinal Chemistry +14

1,3,8-Triazaspiro[4.5]decane-2,4-diones as Efficacious Pan-Inhibitors of Hypoxia-Inducible Factor Prolyl Hydroxylase 1–3 (HIF PHD1–3) for the Treatment of Anemia

Petr Váchal, Shouwu Miao, Joan M. Pierce et al. · Journal of Medicinal Chemistry · 2012 · 66 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

High-Throughput Purification Platform in Support of Drug Discovery

Min Liu, Kuanchang Chen, Denny Christian et al. · ACS Combinatorial Science · 2011 · 46 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

An affinity selection–mass spectrometry method for the identification of small molecule ligands from self-encoded combinatorial librariesDiscovery of a novel antagonist of E. coli dihydrofolate reductase

D. Allen Annis, John Athanasopoulos, Patrick F. Curran et al. · International Journal of Mass Spectrometry · 2004 · 42 citations

Pharmacy, Biochemistry, Medicinal Chemistry +17

Application of Affinity Selection/Mass Spectrometry to Determine the Structural Isomer of Parnafungins Responsible for Binding Polyadenosine Polymerase

Gregory C. Adam, Craig A. Parish, Douglas Wisniewski et al. · Journal of the American Chemical Society · 2008 · 27 citations

Life Sciences, Microbiology, Molecular Biology +17

1–5 of 7